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Summary
Many aspects of mammalian physiology are driven through
the coordinated action of internal circadian clocks. Clock
speed (period) and phase (temporal alignment) are funda-
mental to an organism’s ability to synchronize with its envi-
ronment. In humans, lifestyles that disturb these clocks,
such as shift work, increase the incidence of diseases
such as cancer and diabetes. Casein kinases 1d and ε are
closely related clock components implicated in period deter-
mination. However, CK1d is so dominant in this regard that it
remains unclear what function CK1ε normally serves. Here,
we reveal that CK1ε dictates how rapidly the clock is reset
by environmental stimuli. Genetic disruption of CK1ε in
mice enhances phase resetting of behavioral rhythms to
acute light pulses and shifts in light cycle. This impact of
CK1ε targeting is recapitulated in isolated brain suprachias-
matic nucleus and peripheral (lung) clocks during NMDA- or
temperature-induced phase shift in association with altered
PERIOD (PER) protein dynamics. Importantly, accelerated
re-entrainment of the circadian system in vivo and in vitro
can be achieved in wild-type animals through pharmacolog-
ical inhibition of CK1ε. These studies therefore reveal a role
for CK1ε in stabilizing the circadian clock against phase shift
and highlight it as a novel target for minimizing physiolog-
ical disturbance in shift workers.Results and Discussion
Accelerated Phase Resetting to Light in Mice LackingCK1ε
Casein kinase 1 (CK1)-mediated phosphorylation and degra-
dation of PERIOD (PER) protein are crucial determinants of
the pace of the circadian clock, and we and others have shown
that CK1d is the principal isoform in regulating clock speed
[1–4]. In contrast, genetic deletion or pharmacological inhibi-
tion of CK1ε has little impact on circadian period in mice ([5];
see Figure S1A available online), despite the two isoforms
being closely related. This lack of effect is not because CK1ε
does not engage the clockwork; in its gain-of-function tau
mutant form, CK1εtau dramatically accelerates circadian
timing [5]. It thus remains unclear what role CK1ε normally
plays in the molecular clockwork.
To address this, we first compared the response ofwild-type
(WT) and CK1ε2/2 mice to single or repeated advancing (6 hr)*Correspondence: david.bechtold@manchester.ac.uk
This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/3.0/).or delaying (12 hr) shifts in the timing of environmental light-
dark (LD) cycles. Both genotypes showed normal entrainment
to a 12:12 hr LD cycle, and progressive adaptation of activity
rhythms in response to a shift in LD cycle (Figure 1). However,
re-entrainment was accelerated significantly in CK1ε2/2 mice
compared with WT animals. In response to a 6 hr advance,
CK1ε2/2 mice entrained w2 days faster than WT mice (WT,
5.8 6 0.3 days; CK1ε2/2, 4.1 6 0.4 days; p < 0.05, U test; n =
13–17/group) (Figures 1A and 1B). Similar rapid re-entrainment
of wheel-running activity was observed in the CK1ε2/2mice in
response to a 12 hr reversal of the LD cycle (WT, 6.8 6
0.4 days; CK1ε2/2, 4.4 6 0.3 days; p < 0.05, U test; n = 8–10/
group) (Figures 1C and 1D). In independent experiments,
accelerated adaption of CK1ε2/2 mice to advancing and
delaying shifts was also observed in rhythms of body temper-
ature (Tb), non-wheel-running locomotor activity, and oxygen
consumption (Figures S1B–S1D). Desynchrony among internal
tissue clocks (and the downstream physiological rhythms they
drive) is evident during re-entrainment, as different peripheral
tissues exhibit different rates of resetting [6, 7]. By directly
comparing rhythms in Tb and activity in individual mice sub-
jected to LD phase reversal, we observed desynchronization
between the two physiological rhythms (Figure S1E); however,
this state of desynchronywas greatly reduced inCK1ε2/2mice
(3.3 6 0.5 days, with >1 hr phase dissociation between onset
of activity and Tb profiles) compared with WT mice (5.5 6
0.6 days; p < 0.05, U test).
WT and CK1ε2/2 mice were next subjected to four consec-
utive 6 hr advancing shifts, each separated by 7 days (Fig-
ure 1E; n = 10 or 11/group). As observed with an acute phase
shift, CK1ε2/2 mice were able to repeatedly re-entrain to
each new light cycle faster than WT mice, such that the total
number of jet-lagged days (defined as >1 hr phase misalign-
ment between activity onset and lights-off) over 4 weeks
was significantly reduced in the CK1ε2/2 mice (WT, 14.3 6
1.0 days; knockout [KO], 8.76 1.7 days; p < 0.01, U test). Inter-
estingly, levels of circulating glucagon and insulin exhibited
significant negative and positive correlations, respectively,
with the severity of jet lag in CK1ε2/2 mice (Figure 1F;
glucagon: r =20.66, p < 0.05; insulin: r = 0.69, p < 0.05, Pearson
correlation), and WT mice that exhibited particularly slow
phase adaption exhibited greatly elevated circulating insulin
(Figure 1H). No genotype differences were observed in these
hormones in nonshifted mice (insulin: WT, 2.1 6 0.4 ng/ml;
CK1ε2/2, 2.5 6 0.4 ng/ml; glucagon: WT, 0.4 6 0.1 ng/ml;
CK1ε2/2, 0.5 6 0.1 ng/ml; Figure S2A). Circadian disruption
caused by constant light exposure has been shown to in-
crease weight gain and decrease insulin sensitivity in mice
[8], and in humans, chronic shift work is associated with an
increased incidence and severity of clinical pathologies,
including diabetes [9–11]. Combined with the observation of
reduced desynchronization between rhythms in Tb and loco-
motor activity rhythms (Figure S1E), and accelerated restora-
tion of normal rhythms in metabolic rate following acute phase
shift (Figure S1B), these results suggest that rapid re-entrain-
ment (or at least that achieved through CK1ε targeting) is
beneficial for maintaining metabolic homeostasis during a
phase shift.
Enhanced Clock Resetting in CK1ε2/2 Mice
767We next assessed whether accelerated re-entrainment of
CK1ε2/2 mice to shifts in the LD environment reflected an
enhanced phase adaption of the suprachiasmatic nucleus
(SCN) and peripheral clockworks to the new LD cycle. To facil-
itate these studies, we bred WT and CK1ε2/2 mice to the
mPER2::Luciferase (Luc) reporter mice [12]. Mice were sub-
jected to a 6 hr advance in the LD cycle; SCN and liver slices
were then collected for in vitro mPER2::Luc recording on the
second day postshift (Figures 1G and 1H). Both genotypes
exhibited a significant phase shift in SCN rhythms compared
with slices collected from a matched group of nonshifted
mice. However, the magnitude of phase advance was signifi-
cantly greater in the SCN of CK1ε2/2 mice (Figures 1G and
1H). A significantly greater phase advance was also observed
in liver slices derived from CK1ε2/2 mice (Figures 1I and 1J),
suggesting that CK1ε impacts phase resetting of both central
and peripheral clocks.
Circadian clock-independent suppression of locomotor
activity by light can also accelerate re-entrainment [13]. How-
ever, WT and CK1ε2/2 mice did not differ in their entrainment
to long-day (18:6 hr) LD cycles, split (6:6 hr) LD cycles, or
short-frequency (11:11 hr and 10:10 hr) LD cycles (Figure S2),
demonstrating that neither altered light-induced masking nor
aberrant limits of entrainment contribute to the accelerated
resetting of CK1ε2/2 mice. A heightened response to phase-
shifting stimuli can be characteristic of low-amplitude oscilla-
tors [14]; however, as demonstrated here and in previous
studies [5], CK1ε2/2 mice do not exhibit reduced amplitude
rhythms in behavior or SCN oscillation.
CK1ε2/2Mice Exhibit Enhanced Phase Shift in Response to
Light
The accelerated adaptation to shifts in LD cycle suggested an
alteration in the phase-resetting effect of light in the SCN of
CK1ε2/2 mice. To test this, we housed WT and CK1ε2/2 mice
in constant darkness (DD) for >14 days prior to providing an
advancing (circadian time [CT] 22) or delaying (CT14) light
pulse (Figure 2; n = 13–16/group). In line with the accelerated
re-entrainment in CK1ε2/2 mice, light-induced phase shifts
were significantly greater (w30%) in CK1ε2/2mice than those
observed inWTmice in response to either an advancing or de-
laying light pulse (Figures 2A–2C). These findings contrast pre-
vious observationsmade using a different line ofCK1ε2/2mice
[3]; however, mice in that study were initially maintained in DD
for an extended period (>3 months) and subjected to repeated
pulsing, which may have minimized genotype differences.
To determine whether increased phase resetting to light in
CK1ε2/2 mice reflected an altered response within the SCN
itself, we examined clock resetting in SCN slice cultures in
response to the neurotransmitter analogN-methyl-D aspartate
(NMDA). Retinal inputs to the SCN are principally glutamater-
gic, and application of NMDA to the SCN in vivo or in vitro
canmimic the resetting effects of light [15, 16]. Although appli-
cation of NMDA timed for the rise or decline of PER2 expres-
sion induced phase delays or advances, respectively, in the
clockwork of both genotypes (Figures 2E and 2F), SCN tissue
derived from CK1ε2/2 mice exhibited significantly greater
phase delays (p < 0.05, two-way ANOVA; n = 5/group) and ad-
vances (p < 0.05, two-way ANOVA; n = 3–5/group).
Together, these findings demonstrate that loss of CK1ε
activity significantly enhances light-induced phase shift of
the SCN clockwork and indicate that the enzyme normally
buffers the clock against perturbation across multiple phases
of the cycle.CK1ε Influences Nonphotic Phase Responses of the
Clockwork
We next tested whether the altered phase resetting is specific
to the effects of light input to the SCN or is a more general
feature of the clock. Temperature is a potent entraining stim-
ulus for peripheral tissue clocks [17–19]. Therefore, to explore
more directly the impact of CK1ε on circadian clock responses
to nonphotic stimuli, entrainment and phase resetting of SCN
and lung slice cultures to physiologically relevant temperature
cycles (Figure S3) or acute temperature pulses were examined
(Figure 3). For cycling studies, SCN and lung slice cultures
derived from WT and CK1ε2/2 mice were maintained for
7 days on 12 hr, 36C/12 hr, 38.5C temperature cycles, after
which the cycle was reversed and maintained for a further
nine cycles. In both genotypes, SCN and lung rhythms of
mPER2:Luc bioluminescence entrained rapidly (approxi-
mately three cycles) to the reversed temperature cycle, and
this new phase was maintained upon release to constant
conditions (36C). These data clearly demonstrate that, in
contrast to recent suggestion [17–19], SCN tissue slices are
responsive to a temperature-induced phase shift. However,
other groups have also reported temperature responses of
the SCN [20, 21]. The rapid entrainment of SCN and lung
tissues to a reversal of the temperature cycle (2–3 days) makes
it difficult to discern whether loss of CK1ε enhanced re-
sponses. However, CK1ε2/2-derived tissues exhibited less
disruption in rhythmicity during the temperature reversal and
showed an accentuated shift response in the lung clock
rhythms compared with WT slices (Figure S3; p < 0.05,
repeated-measures two-way ANOVA).
Next, phase-response curves (PRCs) were generated for
SCN and lung slice cultures derived from WT or CK1ε2/2
mice (Figure 3). Tissue slices (n = 42–50 slices/tissue/geno-
type) were maintained at a constant temperature of 36C for
three cycles prior to receiving a 2 hr ambient temperature
pulse of 38.5C, administered to individual slice cultures at
different phases across the circadian cycle. The resulting
phase shift was measured as the difference in the observed
and predicted peaks of mPER2:Luc bioluminescence (Figures
3A and 3B). A significant phase dependence of temperature-
induced shift was observed in WT-derived SCN slices (Fig-
ure 3C; CT time of pulse: F(6,91) = 4.3, p < 0.001; genotype:
F(1,91) = 0.23, two-way ANOVA) and lung slices (Figure 3E;
CT time of pulse: F(6,80) = 13.8, p < 0.001; genotype:
F(1,80) = 0.24, two-way ANOVA). The temperature PRC of the
SCN generated here is strikingly similar to that previously
generated in rat SCN slices using electrical activity recording
[20]. Interestingly, the shape of the temperature PRC differed
between SCN and lung tissues, such that pulses delivered be-
tween CT9 and CT15 elicited amaximal phase advance in SCN
slices but induced phase delays in lung. This observation par-
allels the difference in the direction of phase re-entrainment of
the two tissues observed in the temperature cycle reversal
experiments (Figure S3). Although the temporal phase depen-
dence of the temperature PRC was similar between geno-
types, CK1ε2/2-derived SCN tissue exhibited significantly
greater variability in phase shift responses compared to
WT tissue (F = 2.8, p < 0.001, F test). A similar heightened
variability in temperature-induced shift was also revealed in
CK1ε2/2-derived lung tissue pulsed between CT4 and CT20
(Figure 3F; F = 2.1, p < 0.05, F test). Taken together, these find-
ings indicate that the influence of CK1ε on phase adaption is a
general property of the clockwork, affecting central and pe-
ripheral clock responses to photic and nonphotic stimuli.
Figure 1. Rapid Entrainment of Behavioral and Physiological Rhythms to Single or Repeated Phase Shifts in CK1ε2/2 Mice
(A–D) WT and CK1ε2/2 mice were entrained to a 12 hr/12 hr light-dark (LD) cycle for >7 days and then subjected to a 6 hr advance (A and B; n = 13–17/
genotype) or 12 hr delay (C and D; n = 8–10/genotype) of the LD cycle. As shown by representative actogram records of wheel-running locomotor activity
(A and C) or group analysis of activity onset (B and D), CK1ε2/2 mice entrained to the new LD phase significantly faster than WT mice. Shading indicates
lights-off. Data shown are mean 6 SEM; **p < 0.01, repeated-measures two-way ANOVA.
(legend continued on next page)
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Figure 2. Enhanced Acute Phase Shift Response in CK1ε2/2 Mice In Vivo and CK1ε2/2-Derived SCN In Vitro
(A–C)WT andCK1ε2/2miceweremaintained in constant darkness (DD) forw2weeks (free-running periods:WT, 24.16 0.02 hr;CK1ε2/2, 24.36 0.09 hr) and
then exposed to light for 1 hr at CT22 (advancing pulse; A) or CT14 (delaying pulse; B). As shown in representative double-plotted actogram records of
wheel-running activity (A and B) and analysis of mean phase shift responses (C; n = 10/group), CK1ε2/2 mice exhibit significantly greater shifts in activity
onset compared withWTmice, irrespective of the timing of the light pulse. Histograms reflect mean6 SEM; ***p < 0.001, t test. Arrowhead represents day of
light pulse; black lines on the actograms highlight the phase of activity onset pre and post light pulse.
(D and E) To mimic photic input into the SCN in vitro, we kept SCN slice cultures collected from WT and CK1ε2/2mice under constant temperature of 37C
and treated them with NMDA (30 mM, 30 min) at either the rise or decline of mPER2:Luc oscillations. Phase delays (or advances) in response to rise (or
decline, respectively) in NMDA treatment were measured as the phase difference in the expected (thin gray waveform in D) and observed posttreatment
peak of PER2 (thick black oscillation in D). CK1ε2/2-derived SCN exhibited greater shifts in mPER2:Luc rhythm in response to NMDA treatment compared
with WT slices, irrespective of the direction of shift (E). ***p < 0.001, two-way ANOVA with Tukey’s post hoc test.
Enhanced Clock Resetting in CK1ε2/2 Mice
769Previous reports have suggested that CK1ε plays a role in
temperature compensation of the molecular clockwork
[22, 23]. To ensure that this possibility did not confound
our studies, we tested the effect of ambient temperature
on periodicity of mPER2:Luc rhythms in SCN and lung slice
cultures derived from WT and CK1ε2/2 mice (Figure S3). No
significant differences in the temperature dependence of
circadian period were observed between genotypes, and
both tissues exhibited robust temperature compensation
(SCN Q10: WT, 1.1; CK1ε2/2, 1.1; lung Q10: WT, 0.9;
CK1ε2/2, 0.9). This suggests that CK1ε is not essential for
temperature compensation, likely due to temperature-
compensated activity of CK1d.(E and F)WT andCK1ε2/2micewere subject to four consecutive 6 hr advancing
in representative actogram records of wheel-running activity (E), CK1ε2/2 mic
Analysis of serum collected 7 days after the final shift revealed that levels of circ
relations, respectively, with severity of jet lag (‘‘jet-lag day’’ defined as >1 hr ph
(F; glucagon: r = 20.66, p < 0.05; insulin: r = 0.69, p < 0.05, Pearson correlatio
(G–J) The relative phasing of suprachiasmatic nucleus (SCN) and liver clocks in
mice using ex vivo analysis of mPER2::Luc bioluminescence recording (n = 5–
exhibited an advanced phase compared with nonshifted controls (G); this phas
greater advancement in phase was also observed in liver slices collected fro
mean 6 SEM; **p < 0.01, *p < 0.05, t test.Pharmacological Inhibition of CK1ε Enhances Phase
Resetting
Our results demonstrate a role for CK1ε in stabilizing the circa-
dian clockwork against photic- and nonphotic-induced phase-
resetting stimuli. We next tested whether the enhanced phase
resetting observed in CK1ε2/2 mice could be recapitulated in
WT mice and tissues by pharmacological inhibition using a
highly selective inhibitor of CK1ε, PF4800567 (>20-fold selec-
tivity for CK1ε over CK1d [1]). Indeed, administration of
PF4800567 (100 mg/kg) enhanced the phase shift response of
DD-housed WT mice to either an advancing (CT22) or delaying
(CT14) lightpulse (Figures4Aand4B). Furthermore, inSCNslice
cultures treated with NMDA, application of PF4800567 (1 mM,shifts in LD cycle, each separated by 7 days (n = 10–12/genotype). As shown
e showed accelerated entrainment to each shift in environmental LD cycle.
ulating glucagon and insulin exhibited significant negative and positive cor-
ase misalignment between activity onset and lights-off) in the CK1ε2/2mice
n).
response to a 6 hr advancing phase shift was assessed in WT and CK1ε2/2
7 mice/group). SCN slices collected at ZT6 2 days after in vivo phase shift
e advancement was significantly greater in CK1ε2/2mice (H). A significantly
m CK1ε2/2 mice compared with WT animals (I and J). Histograms reflect
Figure 3. Temperature-Induced Phase Resetting
of Central and Peripheral Clocks
Temperature pulse-induced phase response
curves (PRCs) were generated for WT and
CK1ε2/2-derived SCN (A, C, and D) and lung
(B, E, and F) clocks using ex vivo mPER2:Luc
bioluminescence recording (n = 42–50 slices/
tissue/genotype). A temperature pulse (2 hr,
38.5C) was applied, and phase shift was calcu-
lated as difference between the expected (thin
gray waveform) and observed (thick black line)
peaks in bioluminescence post temperature
pulse (A and B). A clear phase-dependent PRC
was observed in both tissues (C and E). Impor-
tantly, in comparison to WT-derived tissues,
the variability of temperature-induced phase
shifts was significantly increased in CK1ε2/2
SCN (p < 0.05, F test), indicating a role for this
enzyme in stabilizing phase responses of the
SCN clockwork to nonphotic stimuli. A similar
increase in variability was observed in CK1ε2/2
lung cultures. Data points reflect independent
slice cultures shown with median (line) 6 inter-
quartile range. *p < 0.05, **p < 0.01 versus
CT15–CT18 in (C) and (D); *p < 0.05, **p < 0.01
versus CT12–CT16 in (E) and (F); two-way
ANOVA with Tukey’s post hoc test.
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770fromtime0)waseffectiveat increasing themagnitudeofNMDA-
induced phase shift of mPER2:Luc rhythms in WT-derived
tissue (Figures4Cand4D;p<0.01; n=5or 6/group). In contrast,
PF4800567didnotalter themagnitudeofNMDA-inducedphase
shift in CK1ε2/2 tissue. This indicates that the enhanced phase
shift in WT SCN is specifically due to targeting of CK1ε.
Phase resetting of behavioral andmolecular rhythms by light
has been well characterized and in simplified terms reflects an
intensity-dependent induction of Per expression in the SCN
[24, 25]. Inhibition of CK1 activity has been shown to attenuate
rates of PER phosphorylation-mediated degradation in SCN
and peripheral tissues [1–5, 26]. Consistent with CK1-induced
PER2 degradation and enhanced phase shift responses
following CK1ε inhibition, the acute induction of mPER2:Luc
bioluminescence in WT SCN in response to NMDA application
was significantly enhanced by preincubation with PF4800567
(Figure 4E; Figure S4; p < 0.05, two-way ANOVA). Therefore,
CK1ε-mediated degradation of PER may normally serve to
limit protein accumulation (and resulting phase shifts) in
response to light stimulation.
Importantly, pharmacological inhibition in vivo was also
effective in accelerating entrainment to shifts in LD cycle. WT
mice were implanted with 7-day-release osmotic minipumps
containing either vehicle or PF4800567 (12.5 mg/hr). Two days
postimplantation,micewere subjected to a 6hr phase advance
of the LD cycle. Mice treated with PF4800567 re-entrained
locomotor activity rhythms significantly faster to the new LD
cycle (Figures 4F and 4G; vehicle, 5.5 6 0.4 days; PF4800567,
4.3 6 0.4 days; p < 0.05, U test; n = 14/group). This ability of
pharmacological inhibition of CK1ε to phenocopy the genetic
deletion demonstrates that altered shift responses in the KO
mice are not due to a developmental impact of CK1ε KO.
Conclusions
Our results reveal a novel role for CK1ε in resetting of the
mammalian circadian clockwork. Targeting of CK1ε by geneticor pharmacological means increased the responsiveness of
both central and peripheral clocks to phase-shifting stimuli.
This enhanced phase shift response and/or entrainment was
demonstrated in vivo and in vitro, and in response in both
photic (light in vivo, NMDA treatment in vitro) and nonphotic
(temperature) paradigms. Our results indicate that a principle
role of CK1ε in the clock may be to limit PER protein accumu-
lation in response to resetting stimuli, and in so doing buffer
the clockwork against phase shifts. Selective pressure for
such a phase-control mechanism can be envisioned, as it
would prevent uncoordinated phase change in response to
acute fluctuations in the environment (e.g., weather, predation,
food availability). In modern society, however, our lifestyle
presents a problem, requiring rapid adaptation of behavioral
and physiological rhythms to shift-work schedules or long-
haul air travel to which we are not genetically preadapted.
Based on our results, inhibition of CK1ε appears to render
the SCN less resistant to external perturbation, and hence it
resets more rapidly to the external environment. Our studies
highlight CK1ε as a potential target for alleviating the detri-
mental effects of chronic shift work and jet lag.
Experimental Procedures
Animals
Male WT (mPER2::Luc [12]) and CK1ε2/2 (CK1ε2/2mPER2::Luc [5]) mice
10–16 weeks of age were used for all behavioral experiments. Both males
and females were used for ex vivo tissue culture experiments. All experi-
ments were conducted under the aegis of the 1986 Home Office Animal
Procedures Act (UK) and local ethical review.
Behavioral Analysis
Wheel-running activity was recorded and analyzed usingClockLab software
(Actimetrics). During 6 hr phase advance, the dark phase was shortened by
6 hr, whereas during 12 hr phase delay, the dark phase was extended by
12 hr. To induce phase shift response to acute light pulse, we housed
CK1ε2/2 and WT mice in constant darkness (DD) forw14 days. A 1 hr light
pulse was administered at CT14 or CT22, followed by 2 weeks of free run in
Figure 4. Pharmacological Inhibition of CK1ε Enhances Phase Resetting In Vitro and In Vivo
(A and B) WTmice were maintained in DD and then exposed to light for 1 hr at CT14 (delaying pulse; A, top) or CT22 (advancing pulse; A, bottom). Vehicle or
CK1ε inhibitor PF4800567 (PF480, 100mg/kg) was administered as themicewere returned to DD. Another set ofmice received PF4800567 at the appropriate
times (CT15 and CT23) but were not exposed to a light pulse. As shown in representative double-plotted actogram records of wheel-running activity (A) and
analysis of mean phase shift responses (B; n = 6 or 7/group), PF4800567 administration significantly increased light-induced phase shifts. Arrowheads indi-
cate day of pulse; black lines on the actograms highlight the phase of activity onset pre and post light pulse. Histograms reflect mean 6 SEM; *p < 0.01
versus PF4800567 alone; #p < 0.01 versus pulse + vehicle by one-way ANOVA.
(C–E) SCN slices cultures collected from WT and CK1ε2/2 mice were treated with NMDA (30 mM, 30 min; n = 5 or 6/group) in the presence or absence of
PF4800567 (1 mM, chronic application from time 0). PF4800567 had no significant effect on period or phase ofmPER2:Luc bioluminescence rhythms in either
genotype prior to NMDA. However, CK1ε inhibition increased significantly the delaying phase shift in response to peak treatment with NMDA inWT- but not
CK1ε2/2-derived SCN slices (C and D). Phase delays in response to NMDA treatment were measured as the phase difference in the expected (thin gray
waveform) and observed posttreatment peak of PER2 (thick black/red oscillations) (C). PF4800567 significantly enhanced the acute induction of PER2::Luc
in response to NMDA in WT- but not CK1ε2/2-derived SCN slices (E). Data reflect individual recordings (C) and group mean 6 SEM (D). *p < 0.01 versus
vehicle treatment, #p < 0.01 versus NMDA-treated WT, two-way ANOVA with Tukey’s post hoc test.
(F and G) Assessment of pharmacological inhibition of CK1ε on phase resetting in vivo. WTmice were entrained to a 12:12 LD cycle before implantation of a
7-day-release osmotic minipump containing either vehicle or PF4800467 (12.5 mg/hr; n = 14/group). Two days postimplantation, the mice were subjected to
a 6 hr phase advance of the LD cycle (F), and daily onset of activity was determined each day (G). Mice treated with PF4800567 exhibited a significant
acceleration in the time required to re-entrain locomotor activity rhythms to the new LD cycle. Shading indicates lights-off; red crosses indicate the timing
of pump implantation. Results are presented as representative actograms ofwheel-running locomotor activity (F) andmean6SEM for daily phase of activity
onset (G). **p < 0.01, repeated-measures two-way ANOVA.
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772DD. In selected experiments, WT mice were administered PF4800567
(100 mg/kg) or vehicle (20% cyclodextrin) at the end of the light pulse
(CT15 or CT23). Phase shift calculations are detailed in Supplemental Exper-
imental Procedures.
Tissue Collection for Ex Vivo Phase Analysis
WT and CK1ε2/2mice were subjected to a 6 hr advance of the LD cycle. On
the second day postshift, mice were culled at zeitgeber time (ZT) 6 of the
new LD cycle, and SCN and liver slices were collected for mPER2::Luc
recording. A parallel set of mice were not subject to the LD shift and were
used as ‘‘nonshifted controls.’’ Phase was measured as the time of the first
peak in mPER2::Luc activity after 24 hr in culture.
Repeated Phase Shift and Serum Analysis
Mice were subjected to a 6 hr phase advance every 7 days for 4 weeks. On
the seventh day after the final shift, mice were fasted for 4 hr, and trunk
blood was collected at ZT6. Serum insulin and glucagon levels were
measured using a mouse diabetes Bio-Plex plate (Bio-Rad) following the
manufacturer’s instructions.
Osmotic Pump
After 7 days of acclimation to wheel-running cages, WT mice were im-
planted with osmotic minipumps (ALZET Osmotic Pumps Alzet 2001)
containing either vehicle (20% cyclodextrin) or PF4800567 (delivered at
12.5 mg/hr for w7 days). Two days after pump implantation, the LD cycle
was advanced by 6 hr.
Tissue Culture
Bioluminescence recordings were collected using individual photomulti-
plier tubes or lumicycle recorder housed within a temperature-cycling incu-
bator. Briefly, WT mPER2::Luc- and CK1ε2/2 mPER2::Luc-derived tissue
slices were cut and collected as described previously [2]. For NMDA treat-
ments, incubation temperaturewas held at 37C throughout the experiment.
NMDA (30 mM) [27] was rapidly added to SCN culture dishes at the appro-
priate CT, and recording medium was replaced30 min later. The application
of NMDA occurred shortly before the third peak or third nadir of PER2 to
induce advances or delays, respectively. To calculate the magnitude of
phase resetting, we overlaid the waveform of the NMDA-treated cycle on
that of the projected cycle (generated from the two pretreatment cycles).
Selective inhibition of CK1ε was achieved by chronic administration of
PF4800567 (1 mM) to the recording media [2]. For generation of temperature
PRC, slice cultures were maintained at 36C for at least three cycles, after
which incubator temperature was raised to 38.5C for 2 hr.
Statistical Analysis
Results are presented as mean 6 SEM. Statistical significance of group
comparisons was tested with Student’s t test or Mann-Whitney U test for
simple intergenotype differences. Multivariate experiments (e.g., genotype
and treatment) were analyzed using two-way ANOVA with Tukey’s post
hoc analysis. A repeated-measures adjustment was employed when appro-
priate (e.g., daily onset profiles). An F test was used to assess the differ-
ences in variability to temperature-induced phase shifts between
genotypes.
Supplemental Information
Supplemental Information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.
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